RxDoctor Payments Data

Navjot Kohli, MD

Orthopaedic Surgery · Milwaukee, WINPI 1831179506

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $110,650 of the $145,013 with a category attached, or 76.3%. Smith+Nephew accounts for 79.3% of it on its own, with 2 other manufacturers making up the rest. Among orthopaedic surgery clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$145,013in general payments, 2019–2025

Across 82 payments — averaging $1768.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$115K
  • Stryker$30K
  • Medtronic$135

What the payments were for

  • Royalty or licence$110,65076%
  • Consulting fees$23,60016%
  • Travel & lodging$8,4596%
  • Food & beverage$2,3032%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew57$114,945
Stryker24$29,932
Medtronic1$135

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,013 in reported general payments places this provider in the 95th percentile of 498 orthopaedic surgery providers in Wisconsin.

See all orthopaedic surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$221,682
Medicare patients
438
Services billed
18,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$776
Methylprednisolone59$375
Tizanidine Hcl39$233
Meloxicam59$136
Cyclobenzaprine Hcl24$76
Tramadol Hcl18$76
Morphine Sulfate ErMorphine Sulfate11$60
Amoxicillin41$47
Clindamycin Hcl17$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →